We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

37 hedge funds and large institutions have $33.8M invested in Zomedica Corp. in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,500% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 1

2,005% more capital invested

Capital invested by funds: $1.61M → $33.8M (+$32.2M)

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

208% more funds holding

Funds holding: 1237 (+25)

Holders
37
Holders Change
+25
Holders Change %
+208.33%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
7
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q2 2018 in Review

37 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2018, worth a combined $33.8M — up 2,005% from $1.61M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ZOM positions and 1 closed out — a net gain of 25 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Cambridge Investment Research Advisors, adding an estimated $23.9M. The largest seller was Millennium Management, exiting entirely with an estimated $895K sold.

  • 37 institutional investors held Zomedica Corp. (ZOM) as of Q2 2018, up from 12 in Q1 2018.
  • Funds reported $33.8M of Zomedica Corp. stock for Q2 2018, up 2,005% quarter-over-quarter.
  • 26 funds opened new Zomedica Corp. positions in Q2 2018 and 1 closed out, a net change of +25 holders.
  • The largest Zomedica Corp. buyer in Q2 2018 was Cambridge Investment Research Advisors, an estimated $23.9M added.
  • The largest Zomedica Corp. seller in Q2 2018 was Millennium Management, an estimated $895K sold.

Based on aggregated 13F filings for Q2 2018.